IPEX — Inflection Point Acquisition Corp. V Class A
IPEX (Inflection Point Acquisition Corp. V Class A) stock: $9.60, $35.2M market cap, $0.1M cash, $35.1M EV, $104.8M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
Share price
$9.60
Market cap
$35.2M
Cash
$0.1M
Enterprise value
$35.1M
Balance sheet
Cash
$0.1M
Debt
$0.0M
Net cash
$0.1M
Enterprise value
$35.1M
Basic shares
10.9M shares
Fully diluted shares
10.9M shares
Fully diluted market cap
$104.8M
Cash per share
$0.01
Cash figures as of 2026-06-30. Database snapshot: 2026-09-22.
Price history
Loading IPEX daily closes…
Loading price history…
Asset data not yet available for this company.
No lead program on file for this company.
No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.
No specialist-fund holders in 13F data for this company.
Get the weekly biotech catalyst rundown. Cash runways, financings, and trial readouts for all 714 stocks.